UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013654
Receipt number R000015938
Scientific Title Clinical trial of Carperitide and Torasemide (HANSAM therapy) in cardiac surgery (HANSAM trial).
Date of disclosure of the study information 2014/04/07
Last modified on 2021/04/12 09:34:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of Carperitide and Torasemide (HANSAM therapy) in cardiac surgery (HANSAM trial).

Acronym

HANSAM trial

Scientific Title

Clinical trial of Carperitide and Torasemide (HANSAM therapy) in cardiac surgery (HANSAM trial).

Scientific Title:Acronym

HANSAM trial

Region

Japan


Condition

Condition

valve disease, thoracic aortic aneurysm, angina, myocardial infarction et.al.

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reserch the effects of carperitide and torvaptan in caridac surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Urine volume

Key secondary outcomes

1) BNP
3) renin activity, angiotensin-II, aldsterone
4) CK-MB, Tp-I, H-FABP
5) serum creatinine (sCr)
6) mortality, complication
7) postoperative death (early, late)
8) MACCE


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

intra-and perioperative administration of carperitide and postoperative administration of torvaptan

Interventions/Control_2

intra-and perioperative administration of carperitide and postoperative administration of frosemide only

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patient undergoing cardiac surgery
patients from whom informed consent was obtained

Key exclusion criteria

cardiogenic shock
hemodiaisis
Doctor's decision not to register to this regimen

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Sezai

Organization

Nihon University school of medicine

Division name

Department of Cardiovascular Surgery

Zip code


Address

30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Email

asezai.med@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Akira Sezai

Organization

Nihon University School of Medicine

Division name

Department of Cardiovascular Surgery

Zip code


Address

30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Homepage URL


Email

asezai.med@gmail.com


Sponsor or person

Institute

Nihon University Itabashi Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 02 Month 01 Day

Date of IRB

2013 Year 02 Month 05 Day

Anticipated trial start date

2014 Year 04 Month 07 Day

Last follow-up date

2021 Year 04 Month 12 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 07 Day

Last modified on

2021 Year 04 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015938


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name